75% of Treatment-Naïve Patients with Chronic Hepatitis C Achieve SVR (Viral Cure) with Telaprevir-Based Treatment in …

75% of Treatment-Naïve Patients with Chronic Hepatitis C Achieve SVR (Viral Cure) with Telaprevir-Based Treatment in …
CAMBRIDGE, Mass.—-Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus who had not previously been treated achieved a sustained viral response after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial. 69% of people …

Read more on Business Wire via Yahoo! Finance

More Meth Drug Addiction Info:

• Hepatitis b – can it be cured? | Christian Little
• Vertex Hepatitis C Drug Passes Pivotal Test, Cures Three Out of …
• World Hepatitis Day 2010 – This is Hepatitis
• After Hours Report: Netezza Corp. (NYSE:NZ), Vertex …
• Vertex Hepatitis C Drug Performs Well in Clinical Trial : dBTechno
• Good News For Anadys | Daily Markets
• Chart of the Day: Vertex Pharmaceuticals (VRTX) « Sumfolio.com …
• La Protein Required for Internal Ribosome Entry Site-Directed …
• The Medical Quack: Vertex Hepatitis C Drug Curing 3/4 of Patients …
• All About Hepatitis Virus and Disease » Take the Hepatitis C Quiz …